BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35583472)

  • 1. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
    Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
    Ikeda K; Kakehi E; Adachi S; Kotani K
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fever with lymphadenopathy - Kikuchi Fujimoto disease, a great masquerader: a case report.
    Dalugama C; Gawarammana IB
    J Med Case Rep; 2017 Dec; 11(1):349. PubMed ID: 29246252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures.
    Xu S; Sun W; Liu J
    BMC Oral Health; 2019 Oct; 19(1):223. PubMed ID: 31638953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The co-occurrence of Kikuchi-Fujimoto disease and systemic lupus erythematosus: a case report.
    Yousefi M; Rukerd MRZ; Binafar H; Shoaie S; Mirkamali H; Pourzand P; Kaveh R
    J Med Case Rep; 2023 Oct; 17(1):448. PubMed ID: 37884991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report.
    Racette SD; Alexiev BA; Angarone MP; Bhasin A; Lima K; Jennings LJ; Balasubramanian S; Matsuoka AJ
    BMC Infect Dis; 2021 Aug; 21(1):740. PubMed ID: 34344305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) of axillary lymph nodes.
    Nagaraju S; Vaishnav S; Burke LH; Norman EM
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25564582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine: diagnosis and management.
    Betancur V; Net J; Chapman J; Yepes M
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36585044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kikuchi-Fujimoto disease, a rare cause of lymphadenopathy in Africa. Description of the first case in Senegal and review of the literature.
    Lame CA; Loum B; Fall AK; Cucherousset J; Ndiaye AR
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Oct; 134(5):347-349. PubMed ID: 28279633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report: Kikuchi-Fujimoto disease].
    Ergönül O; Kocagül Celikbaş A; Altin N; Eren S; Baykam N; Dokuzoğuz B
    Mikrobiyol Bul; 2004 Oct; 38(4):455-9. PubMed ID: 15700674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kikuchi-Fujimoto Diseasae: An Important Differential of Tuberculous Lymphadenitis.
    Sultan S; Mushtaq H; Manan A
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):987-988. PubMed ID: 33036688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
    Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
    [No Abstract]   [Full Text] [Related]  

  • 13. Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: a case report.
    Kido H; Kano O; Hamai A; Masuda H; Fuchinoue Y; Nemoto M; Arai C; Takeda T; Yamabe F; Tai T; Kasahara M; Suzuki K; Shiraga N; Sadamoto S; Wakayama M; Takahashi Y; Iwasaki Y; Shibuya K; Urita Y
    BMC Neurol; 2017 Feb; 17(1):22. PubMed ID: 28143446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Self-limited lymphadenopathy mimicking lymphoma or lupus (Kikuchi-Fujimoto disease)].
    Solt I; Gatas N; Cohen Y; Rimon D
    Harefuah; 1999 Jan; 136(1):34-6, 94. PubMed ID: 10914156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.
    Moreno de Juan G; Pérez Del Barrio A; Herrera Romero EG; González Ruiz M; Montes Moreno S
    Rev Esp Patol; 2024; 57(1):42-47. PubMed ID: 38246709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
    Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
    Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kikuchi disease: An alternative diagnosis in patients with axillary lymphadenopathy.
    Joral Del Hoyo S; Gallego Verdejo M; González Fuentes MS
    Radiologia (Engl Ed); 2022; 64(6):585-588. PubMed ID: 36402544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kikuchi-Fujimoto Disease: part of the differential diagnosis of cervical lymphadenopathy in an HIV-positive patient.
    Thomson-Glover R; Lawton M; Menon G
    Int J STD AIDS; 2015 Jul; 26(8):602-4. PubMed ID: 25080288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kikuchi-Fujimoto Disease Associated With Mycoplasma Pneumoniae Infection.
    Yu RB; Chen YJ; Chang CH; Chen YL; Chen JW
    Ear Nose Throat J; 2024 Apr; 103(4):NP223-NP225. PubMed ID: 34605286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Necrotizing lymphadenitis (Kikuchi-Fujimoto disease) as a rare cause of cervical lymphadenopathies. Diagnosis and differential diagnosis].
    Wüstenberg EG; Theissig F; Offergeld C; Hüttenbrink KB
    Laryngorhinootologie; 2000 Feb; 79(2):93-5. PubMed ID: 10738716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.